المؤلفون: Ducobu, Jean, Scheen, André, Van Gaal, Luc, Velkeniers, Brigitte, Hermans, Michel

المصدر: Acta Cardiologica, 63 (2), 235-48 (2008)

مصطلحات موضوعية: Antilipemic Agents/therapeutic use, Atherosclerosis/epidemiology/etiology/prevention & control, Belgium/epidemiology, Clofibric Acid/therapeutic use, Dyslipidemias/complications/drug therapy/epidemiology, Humans, Morbidity, Risk Factors, Human health sciences, Pharmacy, pharmacology & toxicology, Endocrinology, metabolism & nutrition, Sciences de la santé humaine, Pharmacie, pharmacologie & toxicologie, Endocrinologie, métabolisme & nutrition

Relation: http://www.actacardiologica.be/; urn:issn:0001-5385; urn:issn:1784-973X; https://orbi.uliege.be/handle/2268/9399; info:hdl:2268/9399; https://orbi.uliege.be/bitstream/2268/9399/1/how%20to%20reduce%20the%20residual%20risk%20in%20atherogenic.pdf; info:pmid:18468206

الاتاحة: https://orbi.uliege.be/handle/2268/9399
https://orbi.uliege.be/bitstream/2268/9399/1/how%20to%20reduce%20the%20residual%20risk%20in%20atherogenic.pdf
https://doi.org/10.2143/AC.63.2.2029534